Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardioprotective Effect of Atorvastatin in Lymphoma Patients Receiving CHOP/R-CHOP Regimen
TCTR20180202004Phase 3Recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin in lymphoma, sponsored by Faculty of Medicine, Chiang Mai University. Started Jan 2018; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
lymphoma
Beyond the preview
Go deeper on TCTR20180202004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180202004.